Protein interacting with Amyloid Precursor Protein tail-1 (PAT1) is involved in early endocytosis.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 04 09 2018
accepted: 20 05 2019
revised: 16 05 2019
pubmed: 30 5 2019
medline: 18 12 2019
entrez: 30 5 2019
Statut: ppublish

Résumé

Protein interacting with Amyloid Precursor Protein (APP) tail 1 (PAT1) also called APPBP2 or Ara 67 has different targets such as APP or androgen receptor and is expressed in several tissues. PAT1 is known to be involved in the subcellular trafficking of its targets. We previously observed in primary neurons that PAT1 is poorly associated with APP at the cell surface. Here we show that PAT1 colocalizes with vesicles close to the cell surface labeled with Rab5, Rab4, EEA1 and Rabaptin-5 but not with Rab11 and Rab7. Moreover, PAT1 expression regulates the number of EEA1 and Rab5 vesicles, and endocytosis/recycling of the transferrin receptor. In addition, low levels of PAT1 decrease the size of transferrin-colocalized EEA1 vesicles with time following transferrin uptake. Finally, overexpression of the APP binding domain to PAT1 is sufficient to compromise endocytosis. Altogether, these data suggest that PAT1 is a new actor in transferrin early endocytosis. Whether this new function of PAT1 may have consequences in pathology remains to be determined.

Identifiants

pubmed: 31139847
doi: 10.1007/s00018-019-03157-7
pii: 10.1007/s00018-019-03157-7
doi:

Substances chimiques

Amino Acid Transport Systems 0
Amyloid beta-Protein Precursor 0
Rabep1 protein, mouse 0
Receptors, Androgen 0
Slc36a1 protein, mouse 0
Symporters 0
Vesicular Transport Proteins 0
early endosome antigen 1 0
rab7 GTP-Binding Proteins 0
rab7 GTP-binding proteins, human 0
rab7 GTP-binding proteins, mouse 0
rab11 protein EC 3.6.1.-
rab GTP-Binding Proteins EC 3.6.5.2
rab4 GTP-Binding Proteins EC 3.6.5.2
rab5 GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4995-5009

Références

J Cell Sci. 2008 Oct 15;121(Pt 20):3445-58
pubmed: 18827013
Traffic. 2018 Apr;19(4):253-262
pubmed: 29314494
Cold Spring Harb Perspect Biol. 2014 Oct 23;6(11):a022616
pubmed: 25341920
Mol Biol Cell. 2004 Nov;15(11):4990-5000
pubmed: 15331762
Am J Pathol. 2000 Jul;157(1):277-86
pubmed: 10880397
Cell. 2007 Oct 19;131(2):215-21
pubmed: 17956719
Cell. 2001 Jan 12;104(1):119-30
pubmed: 11163245
J Cell Biol. 1995 Feb;128(4):537-47
pubmed: 7860629
Cell. 1995 Nov 3;83(3):423-32
pubmed: 8521472
FASEB J. 2005 Nov;19(13):1905-7
pubmed: 16162853
EMBO J. 1998 Apr 1;17(7):1941-51
pubmed: 9524117
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14979-84
pubmed: 11742091
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14745-50
pubmed: 9843960
Nature. 2012 May 23;485(7399):465-70
pubmed: 22622570
Cancer Res. 2003 Apr 15;63(8):1876-83
pubmed: 12702577
Mol Endocrinol. 2005 Feb;19(2):350-61
pubmed: 15514032
J Alzheimers Dis. 2008 Feb;13(1):1-16
pubmed: 18334752
EMBO J. 1994 Mar 15;13(6):1287-96
pubmed: 8137813
Brain Pathol. 2002 Oct;12(4):430-41
pubmed: 12408229
Neurobiol Aging. 2011 Jun;32(6):1099-113
pubmed: 19570594
J Biol Chem. 1995 Jun 2;270(22):13503-11
pubmed: 7768953
Neuroscience. 1996 Dec;75(4):1239-54
pubmed: 8938757
Neurobiol Dis. 2003 Dec;14(3):391-403
pubmed: 14678756
Neurobiol Aging. 2016 Oct;46:43-8
pubmed: 27460148
PLoS One. 2011 Jan 27;6(1):e16301
pubmed: 21298006
Mol Psychiatry. 2016 May;21(5):707-16
pubmed: 26194181
Nat Commun. 2018 Mar 13;9(1):1050
pubmed: 29535304
Physiol Rev. 2001 Apr;81(2):741-66
pubmed: 11274343
Mol Cell Biol. 2004 Feb;24(3):1044-57
pubmed: 14729952
Biochim Biophys Acta. 2012 Mar;1820(3):264-81
pubmed: 21968002
BMC Neurosci. 2015 Mar 07;16:10
pubmed: 25880931
Mol Endocrinol. 2000 Jun;14(6):875-88
pubmed: 10847589
J Virol. 2003 Sep;77(17):9192-203
pubmed: 12915535
Biochemistry. 1997 Jul 1;36(26):8145-52
pubmed: 9201963
Sci Rep. 2016 Feb 16;6:21019
pubmed: 26880306
Nat Rev Mol Cell Biol. 2009 Aug;10(8):513-25
pubmed: 19603039
Neurobiol Aging. 2014 May;35(5):958-68
pubmed: 24262202
J Pathol. 2006 Mar;208(4):554-63
pubmed: 16400626
Nature. 1998 Jul 30;394(6692):494-8
pubmed: 9697774
Clin Cancer Res. 2003 Jun;9(6):1995-2004
pubmed: 12796361
J Biol Chem. 1996 Sep 27;271(39):24048-54
pubmed: 8798641
J Biol Chem. 1995 Feb 24;270(8):3565-73
pubmed: 7876092
Cell. 2006 Mar 10;124(5):997-1009
pubmed: 16530046
J Biol Chem. 1996 May 10;271(19):11059-62
pubmed: 8626647
J Neurosci. 1997 Aug 15;17(16):6142-51
pubmed: 9236226
J Biol Chem. 2006 Dec 29;281(52):40114-23
pubmed: 17050537
Cell. 1984 Dec;39(2 Pt 1):267-74
pubmed: 6094009
Hum Mol Genet. 2012 Jul 15;21(14):3156-72
pubmed: 22511594
Mol Cell Neurosci. 2001 Nov;18(5):503-11
pubmed: 11922141
Am J Pathol. 2008 Aug;173(2):370-84
pubmed: 18535180

Auteurs

Aysegul Dilsizoglu Senol (A)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

Lidia Tagliafierro (L)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.
Department of Neurology, Duke University Medical Center, Durham, NC, 27710, USA.

Lucie Gorisse-Hussonnois (L)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

Florian Rebeillard (F)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

Léa Huguet (L)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

David Geny (D)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

Vincent Contremoulins (V)

ImagoSeine, Institut Jacques Monod, UMR 7592, CNRS and Université Paris Diderot, Paris, France.

Fabian Corlier (F)

Institut du Cerveau et la Moelle épinière, ICM, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Paris, France.

Marie-Claude Potier (MC)

Institut du Cerveau et la Moelle épinière, ICM, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Paris, France.

Stéphanie Chasseigneaux (S)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.
INSERM U1144, Université Paris Descartes and Université Paris Diderot UMR-S 1144, 75006, Paris, France.

Michèle Darmon (M)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France.

Bernadette Allinquant (B)

Faculté de Médecine, UMR_S894 INSERM, Université Paris Descartes, Sorbonne Paris Cité, 102-108 rue de la Santé, 75014, Paris, France. bernadette.allinquant@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH